Vikram Jog Net Worth

The estimated Net Worth of Vikram Jog is at least $1.9 Million dollars as of 22 February 2022. Mr. Jog owns over 6,879 units of Standard BioTools Inc stock worth over $508,404 and over the last 14 years he sold FLDM stock worth over $0. In addition, he makes $1,391,440 as Chief Financial Officer at Standard BioTools Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Jog FLDM stock SEC Form 4 insiders trading

Vikram has made over 68 trades of the Standard BioTools Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 6,879 units of FLDM stock worth $25,521 on 22 February 2022.

The largest trade he's ever made was exercising 51,878 units of Standard BioTools Inc stock on 20 May 2021 worth over $192,467. On average, Vikram trades about 4,491 units every 39 days since 2011. As of 22 February 2022 he still owns at least 137,036 units of Standard BioTools Inc stock.

You can see the complete history of Mr. Jog stock trades at the bottom of the page.

Vikram Jog biography

Vikram Jog CPA serves as Chief Financial Officer of the Company. Mr. Jog served as chief financial officer for XDx, Inc. (now CareDx, Inc.), a molecular diagnostics company. From March 2003 to April 2005, Mr. Jog was a vice president of Applera Corporation, a life science company that is now part of Thermo Fisher Scientific, and vice president of finance for its related businesses, Celera Genomics and Celera Diagnostics. From April 2001 to March 2003, Mr. Jog was vice president of finance for Celera Diagnostics and corporate controller of Applera Corporation. Mr. Jog received a Bachelor of Commerce degree from Delhi University and an M.B.A. from Temple University. Mr. Jog is a member of the American Institute of Certified Public Accountants.

What is the salary of Vikram Jog?

As the Chief Financial Officer of Standard BioTools Inc, the total compensation of Vikram Jog at Standard BioTools Inc is $1,391,440. There are 2 executives at Standard BioTools Inc getting paid more, with Stephen Linthwaite having the highest compensation of $3,713,060.

How old is Vikram Jog?

Vikram Jog is 64, he's been the Chief Financial Officer of Standard BioTools Inc since 2019. There are 1 older and 12 younger executives at Standard BioTools Inc. The oldest executive at Standard BioTools Inc is Vikram Jog, 65, who is the Chief Financial Officer.

What's Vikram Jog's mailing address?

Vikram's mailing address filed with the SEC is C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Standard BioTools Inc

Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... und Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.

What does Standard BioTools Inc do?

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.

Complete history of Mr. Jog stock trades at Standard BioTools Inc

Standard BioTools Inc executives and stock owners

Standard BioTools Inc executives and other stock owners filed with the SEC include:

• Stephen Linthwaite,
  President, Chief Executive Officer, Director
• Colin McCracken,
  Chief Commercial Officer
• Vikram Jog,
  Chief Financial Officer
• Bradley Kreger,
  Senior Vice President, Global Operations
• Nicholas Khadder,
  Senior Vice President, General Counsel, Corporate Secretary
• Colin McCracken,
  Chief Commercial Officer
• Vikram Jog,
  Chief Financial Officer
• Bradley Allen Kreger,
  Sr. VP of Global Operations
• Gerhard Burbach,
  Independent Director
• Nicolas Barthelemy,
  Independent Director
• Carlos Paya,
  Independent Chairman of the Board
• Laura Clague,
  Independent Director
• Bill Colston,
  Independent Director
• Angela Peters,
  Chief HR Officer
• Mark Spearman,
  Sr. Director of Corp. Communications
• Peter DeNardo,
  Investor Relations
• Andrew Quong,
  Chief Science Officer
• Dr. Stephen R. Quake D.phil., Ph.D.,
  Co-Founder & Chairman of Advisory Board
• Venture Capital I Lpversant...,
  
• Capital Strategies, L.P.Lev...,
  
• John A Young,
  Director
• Steven Mc Phail,
  GM, PRODUCTION GENOMICS
• Mai Chan Yow,
  VP, WW Mfg & MD-Singapore
• Samuel D Colella,
  Director
• Jennifer Ling Lee,
  See Remarks
• Patrick S Jones,
  Director
• Gajus Vincent Worthington,
  President & CEO
• William Maxwell Smith,
  VP, Legal Affairs & GC
• Marc Unger,
  See Remarks
• Evan/ Fa Jones,
  Director
• Capital Strategies, L.P.Lev...,
  
• Capital Strategies, L.P.Lev...,
  
• Capital Strategies, L.P.Lev...,
  
• Ana K. Stankovic,
  Director
• Robert C Jones,
  Exec. VP, Research & Dev.
• Raymond J Whitaker,
  Director
• Kenneth J Nussbacher,
  Director
• Investments Pte Ltd.Biomedi...,
  
• Jeremy Loh,
  Director
• Partners, L.P.Euclid Sr Bio...,
  
• Easterly Partners Llcle Par...,